3.5. M Stage, Serum S100B, Serum LDH, Clark Level and Primary Tumor Localization Are Significant and Independent Prognostic Factors of Mortality in Metastatic Melanoma Patients Treated with BRAF + MEK Inhibitors. The gene discussed is BRAF; the disease is melanoma.